To the full analysis
Ambev stock: growth
ABEVAmbev reported $15.71B in revenue for fiscal 2025, down 1.4% on the prior year, up 8.6% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
8.9%
per year from 2006 to 2025, per share 8.6%
Earnings (Annual rate)
9.4%
per year from 2006 to 2025, per share 7.3%
Free cash flow (Annual rate)
8.1%
per year from 2006 to 2025, per share 7.8%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 8.6% | 6.6% | 8.9% |
| Revenue per share | 8.8% | 6.6% | 8.6% |
| Earnings | 6.4% | 2.2% | 9.4% |
| Earnings per share | 6.6% | 2.3% | 7.3% |
| Free cash flow | 7.0% | 0.8% | 8.1% |
| Free cash flow per share | 7.2% | 0.9% | 7.8% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $3.14B | $499.62M | $811.74M |
| 2007 | $3.49B | $890.77M | $1B |
| 2008 | $3.69B | $911.37M | $903.57M |
| 2009 | $4.13B | $1.07B | $1.29B |
| 2010 | $4.49B | $1.35B | $1.38B |
| 2011 | $4.83B | $916.23M | $1.69B |
| 2012 | $5.78B | $1.13B | $2.01B |
| 2013 | $6.25B | $1.7B | $2.05B |
| 2014 | $6.78B | $2.15B | $2.03B |
| 2015 | $8.32B | $2.21B | $3.26B |
| 2016 | $8.12B | $2.23B | $1.46B |
| 2017 | $8.53B | $1.29B | $2.68B |
| 2018 | $8.94B | $1.96B | $2.63B |
| 2019 | $9.26B | $2.1B | $2.37B |
| 2020 | $10.39B | $2.03B | $2.52B |
| 2021 | $12.97B | $2.26B | $2.71B |
| 2022 | $14.19B | $2.57B | $2.51B |
| 2023 | $14.2B | $2.58B | $3.33B |
| 2024 | $15.93B | $2.57B | $3.8B |
| 2025 | $15.71B | $2.76B | $3.54B |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = R$5.6169)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral since 13 Nov 2026, previously Strong
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.